Researchers analyzed more than 221,000 patients who underwent a robotic-assisted surgery for five procedures at 1,370 hospitals from 2010 to 2011 to examine an association between hospital competition, hospital financial status and the performance of robotic-assisted surgery.
They found for all five types of surgery — radical prostatectomy, total nephrectomy, partial nephrectomy, hysterectomy and oophorectomy — increased market competition was associated with an increased use of robotic-assisted surgery.
However, the researchers found hospital financial status has a limited association with using robotic-assisted surgery.
“These data imply that regional competition may influence a hospital’s decision to acquire a surgical robot, but once the device is in place, market competition exerts less influence on actual within-hospital use,” according to the authors.
They write that acquiring robots is a type of “medical arms race” where “hospitals in competitive market environments are…faced with the challenge of whether to offer a service of questionable value or potentially lose marketshare to competitors who choose to offer the service.”
More articles on health IT:
Hospital pays $17k ransom to get medical records back from hackers
IBM to acquire Truven Health Analytics for $2.6B
20 hospitals, health systems seeking Cerner, MEDITECH, Epic talent
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
